Long-term patient follow-up should be routinely implemented in radiotherapy units to detect late adverse effects after cancer treatment
DOI:
https://doi.org/10.2340/sju.v58.13470Abstract
Editorial comment to Urosymphyseal fistula after pelvic radiotherapy – an entity in patients with significant comorbidity requiring multidisciplinary management Scand J Urol. 2023
Downloads
References
Moschini M, Zaffuto E, Karakiewicz PI, et al. External beam radiotherapy increases the risk of bladder cancer when compared with radical prostatectomy in patients affected by prostate cancer: A population-based analysis. Eur Urol. 2019;75(2):319–28. https://doi.org/10.1016/j.eururo.2018.09.034 DOI: https://doi.org/10.1016/j.eururo.2018.09.034
Guo X, Liu M, Hou H, et al. Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer. Int J Clin Oncol. 2019;24(8):957–65. https://doi.org/10.1007/s10147-019-01427-9 DOI: https://doi.org/10.1007/s10147-019-01427-9
Zhao S, Xie Q, Yang R, et al. High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis. Cancer Manag Res. 2019;11:587–98. https://doi.org/10.2147/CMAR.S185867 DOI: https://doi.org/10.2147/CMAR.S185867
Martin SE, Begun EM, Samir E, Azaiza MT, Allegro S, Abdelhady M. Incidence and morbidity of radiation-induced hemorrhagic cystitis in prostate cancer. Urology. 2019;131:190–5. https://doi.org/10.1016/j.urology.2019.05.034 DOI: https://doi.org/10.1016/j.urology.2019.05.034
Makino K, Sato Y, Takenaka R, et al. Cumulative incidence and clinical risk factors of radiation cystitis after radiotherapy for prostate cancer. Urol Int. 2023;107(5):440–447. https://doi.org/10.1159/000521723 DOI: https://doi.org/10.1159/000521723
Carlsson S, Bock D, Lantz A, et al. Salvage radiotherapy after radical prostatectomy: functional outcomes in the LAPPRO trial after 8-year follow-up. Scand J Urol. 2023;58:11–9. https://doi.org/10.2340/sju.v58.7318 DOI: https://doi.org/10.2340/sju.v58.7318
Braide K, Kindblom J, Thellenberg Karlsson C, Stattin P, Hugosson J, Mansson M. Risk of severe late toxicity after radiotherapy following radical prostatectomy – a nationwide study. BJU Int. 2022;130(6):799–808. https://doi.org/10.1111/bju.15769 DOI: https://doi.org/10.1111/bju.15769
Fridriksson JO, Folkvaljon Y, Nilsson P, et al. Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study. Scand J Urol. 2016;50(5):338–45. https://doi.org/10.1080/21681805.2016.1194460 DOI: https://doi.org/10.1080/21681805.2016.1194460
David RV, Kahokehr AA, Lee J, Watson DI, Leung J, O’Callaghan ME. Incidence of genitourinary complications following radiation therapy for localised prostate cancer. World J Urol. 2022;40(10):2411–22. https://doi.org/10.1007/s00345-022-04124-x DOI: https://doi.org/10.1007/s00345-022-04124-x
Dearnaley D, Syndikus I, Mossop H, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17(8):1047–60. https://doi.org/10.1016/S1470-2045(16)30102-4 DOI: https://doi.org/10.1016/S1470-2045(16)30102-4
Lane JA, Donovan JL, Young GJ, et al. Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study). BJU Int. 2022;130(3):370–80. https://doi.org/10.1111/bju.15739 DOI: https://doi.org/10.1111/bju.15739
Yu T, Zhang Q, Zheng T, et al. The effectiveness of intensity modulated radiation therapy versus three-dimensional radiation therapy in prostate cancer: a meta-analysis of the literatures. PLoS One. 2016;11(5):e0154499. https://doi.org/10.1371/journal.pone.0154499 DOI: https://doi.org/10.1371/journal.pone.0154499
Kerkmeijer LGW, Groen VH, Pos FJ, et al. Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial. J Clin Oncol. 2021;39(7):787–96. https://doi.org/10.1200/JCO.20.02873 DOI: https://doi.org/10.1200/JCO.20.02873
Hamstra DA, Stenmark MH, Ritter T, et al. Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2013;85(5):1246–53. https://doi.org/10.1016/j.ijrobp.2012.10.042 DOI: https://doi.org/10.1016/j.ijrobp.2012.10.042
David R, Hiwase M, Kahokehr AA, et al. Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer. World J Urol. 2022;40(12):2911–8. https://doi.org/10.1007/s00345-022-04212-y DOI: https://doi.org/10.1007/s00345-022-04212-y
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Kirsti Aas, Amir Sherif
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Acta Chirurgica Scandinavica Society owns the copyright for all material published until Volume 57 (2023) unless otherwise specified. As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.
